Results 11 to 20 of about 450 (147)

Cell-based neurorestorative therapy for postpoliomyelitis syndrome: a case report

Journal of Neurorestoratology, 2016
Haitao Xi,1,2,* Di Chen1,* 1Center of Neurorestoratology, Beijing Hongtianji Neuroscience Academy, 2Center of Neurorestoratology, Beijing Rehabilitation Hospital affiliated Capital Medical University, Beijing, People’s Republic of China *These ...
Xi HT, Chen D
doaj   +4 more sources

Walking in postpoliomyelitis syndrome: The relationships between time-scored tests, walking in daily life and perceived mobility problems [PDF]

Journal of Rehabilitation Medicine, 2005
Objective: To compare walking test results with walking in daily life, and to investigate the relationships between walking tests, walking activity in daily life, and perceived mobility problems in patients with post-poliomyelitis syndrome.
Beelen, A. (Anita), Bussmann, J.B.J. (Hans), Horemans, H.L.D. (Herwin), Nollet, F. (Frans), Stam, H.J. (Henk)   +4 more
core   +8 more sources

Pyridostigmine treatment in postpoliomyelitis syndrome [PDF]

, 2005
Lankhorst, G.J. [Promotor]Nollet, F.
Horemans, H.L.D.
core   +4 more sources

Assessment of energy expenditure in individuals with post-poliomyelitis syndrome [PDF]

Arquivos de Neuro-Psiquiatria, 2017
The objective of this study was to identify energy expenditure, retrospectively, in individuals with post-poliomyelitis syndrome (PPS) in the Brazilian population. Methods The Baecke questionnaire for the evaluation of habitual physical activity (HPA),
Roberto Dias Batista Pereira, Tatiana Mesquita e Silva, Abrahão Augusto Juviniano Quadros, Marco Orsini, Beny Schmidt, Helga Cristina Almeida Silva, Acary Souza Bulle Oliveira   +6 more
doaj   +3 more sources

Pyridostigmine: Postpoliomyelitis Syndrome. [PDF]

Hosp Pharm, 2016
This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or
Generali JA, Cada DJ.
europepmc   +4 more sources

Reliability of Muscle Strength and Muscle Power Assessments Using Isokinetic Dynamometry in Neuromuscular Diseases: A Systematic Review. [PDF]

Phys Ther, 2022
OBJECTIVE: The purpose of this study was to critically appraise and summarize the evidence for reliability of muscle strength and muscle power assessment in patients with neuromuscular diseases (NMDs) using isokinetic dynamometry. METHODS: PubMed, CINAHL,
van der Woude DR, Ruyten T, Bartels B.
europepmc   +3 more sources

Neural Indicators of Fatigue in Chronic Diseases: A Systematic Review of MRI Studies. [PDF]

Diagnostics (Basel), 2018
The authors would like to thank the Sir Jules Thorn Charitable Trust for their financial support.Peer reviewedPublisher ...
Goñi M, Basu N, Murray AD, Waiter GD.
europepmc   +5 more sources

Cell-based neurorestorative therapy for postpoliomyelitis syndrome: a case report [PDF]

Journal of Neurorestoratology, 2016
Haitao Xi, Di Chen
core   +3 more sources

Post-polio syndrome is not a dysimmune condition. [PDF]

Eur J Phys Rehabil Med
Post-polio syndrome; Dysimmune conditionSíndrome post-polio; Condició disimmuneSíndrome pospolio; Condición disinmuneBACKGROUND: Poliomyelitis is a global disabling disease affecting 12-20 million of people.
Laffont I, Duflos C, Hirtz C, Bakhti K, Gelis A, Palayer C, Macioce V, Soler M, Pradalier F, Galtier F, Jentzer A, Lozano C, Vincent T, Morales RJ.   +13 more
europepmc   +3 more sources

Negative-Pressure Ventilation in Neuromuscular Diseases in the Acute Setting. [PDF]

J Clin Med, 2022
Mechanical ventilation started with negative-pressure ventilation (NPV) during the 1950s to assist patients with respiratory failure, secondary to poliomyelitis.
Annunziata A, Calabrese C, Simioli F, Coppola A, Flora M, Marotta A, Di Spirito V, Didonna F, Cicalese M, Fiorentino G.   +9 more
europepmc   +3 more sources